Muscle mass as a modifier of stress response in acute ischemic stroke patients
- PMID: 38698153
- PMCID: PMC11066052
- DOI: 10.1038/s41598-024-60829-6
Muscle mass as a modifier of stress response in acute ischemic stroke patients
Abstract
Stroke triggers a systemic inflammatory response over the ensuing days after the cerebral insult. The age and comorbidities of the stroke population make them a vulnerable population for low muscle mass and sarcopenia, the latter being another clinical condition that is closely associated with inflammation, as shown by increased levels of pro-inflammatory biomarkers, including neutrophil-to-lymphocyte ratio (NLR). In this study, we evaluated the relationship between post-stroke NLR changes and muscle mass in a prospective cohort of acute ischemic stroke patients (n = 102) enrolled in the Muscle Assessment in Stroke Study Turkey (MASS-TR). Admission lumbar computed tomography images were used to determine the cross-sectional muscle area of skeletal muscles at L3 vertebra level and calculate the skeletal muscle index (SMI). The median (IQR) SMI was 44.7 (39.1-52.5) cm2/m2, and the NLR at admission and follow-up were 4.2 (3.0-10.5) and 9.4 (5.7-16.2), respectively. While there was no relationship between SMI and admission NLR, a significant inverse correlation was observed between SMI and follow-up NLR (r = - 0.26; P = 0.007). Lower SMI remained significantly associated (P = 0.036) with higher follow-up NLR levels in multivariate analysis. Our findings highlight the importance of muscle mass as a novel factor related to the level of post-stroke stress response.
© 2024. The Author(s).
Conflict of interest statement
EMA: received honoraria from Sanofi, Abbott, and Nutricia. He served on the advisory boards of Sanofi and Nutricia. LG: received honoraria from Sanofi, Amgen, Nutricia, Nestle, Abbott, and Fresenius-Kabi. He served on the national advisory boards of Nutricia and Fresenius-Kabi. MAT: received honoraria from Sanofi and Abbott. He served on the advisory boards for Abbott and Sanofi. The remaining authors declare no competing interests.
Figures
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
